Id |
Subject |
Object |
Predicate |
Lexical cue |
T5 |
108-119 |
NCBITaxon:11118 |
denotes |
Coronavirus |
T36578 |
108-119 |
NCBITaxon:11118 |
denotes |
Coronavirus |
T6 |
129-137 |
SP_7 |
denotes |
COVID-19 |
T5455 |
129-137 |
SP_7 |
denotes |
COVID-19 |
T7 |
166-172 |
GO:0016265 |
denotes |
deaths |
T54194 |
166-172 |
GO:0016265 |
denotes |
deaths |
T8 |
194-199 |
UBERON:0000062 |
denotes |
organ |
T90485 |
194-199 |
UBERON:0000062 |
denotes |
organ |
T9 |
241-259 |
CHEBI:35705;CHEBI:35705 |
denotes |
immunosuppressants |
T79164 |
241-259 |
CHEBI:35705;CHEBI:35705 |
denotes |
immunosuppressants |
T10 |
296-304 |
SP_7 |
denotes |
COVID-19 |
T39889 |
296-304 |
SP_7 |
denotes |
COVID-19 |
T11 |
376-384 |
SP_7 |
denotes |
COVID-19 |
T93635 |
376-384 |
SP_7 |
denotes |
COVID-19 |
T12 |
429-437 |
SP_7 |
denotes |
COVID-19 |
T83742 |
429-437 |
SP_7 |
denotes |
COVID-19 |
T13 |
458-463 |
UBERON:0000062 |
denotes |
organ |
T91437 |
458-463 |
UBERON:0000062 |
denotes |
organ |
T14 |
481-492 |
DG_35 |
denotes |
tocilizumab |
T91213 |
481-492 |
DG_35 |
denotes |
tocilizumab |
T15 |
497-510 |
PR:000001393 |
denotes |
interleukin-6 |
T94437 |
497-510 |
PR:000001393 |
denotes |
interleukin-6 |
T16 |
512-516 |
PR:000001393 |
denotes |
IL-6 |
T55565 |
512-516 |
PR:000001393 |
denotes |
IL-6 |
T17 |
518-527 |
CHEBI:35222;CHEBI:35222 |
denotes |
inhibitor |
T92863 |
518-527 |
CHEBI:35222;CHEBI:35222 |
denotes |
inhibitor |
T18 |
549-557 |
SP_7 |
denotes |
COVID-19 |
T64846 |
549-557 |
SP_7 |
denotes |
COVID-19 |
T19 |
578-584 |
UBERON:0002113 |
denotes |
kidney |
T10292 |
578-584 |
UBERON:0002113 |
denotes |
kidney |
T20 |
589-594 |
UBERON:0002107 |
denotes |
liver |
T23415 |
589-594 |
UBERON:0002107 |
denotes |
liver |
T21 |
635-646 |
DG_35 |
denotes |
tocilizumab |
T55060 |
635-646 |
DG_35 |
denotes |
tocilizumab |
T22 |
806-814 |
SP_7 |
denotes |
COVID-19 |
T13776 |
806-814 |
SP_7 |
denotes |
COVID-19 |